about
Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion proteinFingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal NeuronsIn vitro aggregation behavior of a non-amyloidogenic λ light chain dimer deriving from U266 multiple myeloma cells.The new β amyloid-derived peptide Aβ1-6A2V-TAT(D) prevents Aβ oligomer formation and protects transgenic C. elegans from Aβ toxicity.Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation.The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β OligomersA recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis.Utilization of the Monte Carlo method to build up QSAR models for hemolysis and cytotoxicity of antimicrobial peptides.Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.Specific recognition of biologically active amyloid-β oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in Caenorhabditis elegans.Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide.Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features.Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity.Cardiac Light Chain Amyloidosis: The Role of Metal Ions in Oxidative Stress and Mitochondrial Damage.QSAR model for blood-brain barrier permeation.Monte Carlo method for predicting of cardiac toxicity: hERG blocker compounds.New mutations in MAPT gene causing frontotemporal lobar degeneration: biochemical and structural characterization.A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodiesA modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ)₁₋₄₀ and Aβ₁₋₄₂ from the corresponding depsipeptidesDoxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse modelsThe Anti-Amyloidogenic Action of Doxycycline: A Molecular Dynamics Study on the Interaction with Aβ42Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects
P50
Q24630045-77EBD2B2-22F6-4DAD-BD03-78728EB567ABQ30836800-24903FCD-26AA-473E-858F-A704BF1149CEQ34202885-7F46D684-3E40-41BE-A002-8D6B6D881E79Q35899630-12DA2326-846A-4350-A3A5-FB30FC97BA60Q36727420-BA1B2A1A-0977-4134-8F57-925E89AA6965Q37300268-DE5ACDE4-FBA0-4DB2-8539-FD95CE6A0B6CQ37309370-C8BAD0B8-8269-4DA1-B28D-20929F8F6430Q38763326-B84041D8-E954-4ACD-BD91-4A00162B55BEQ39727672-92B85052-BFD0-41E4-AEA1-C5E0AD08BB12Q41862324-375F2F37-CBEE-48C2-A64A-FF9ED271E2E5Q43017789-ECBDEB4A-6BC7-42F0-85F4-77ABC170E663Q43493477-C623D369-33F3-482D-AF30-FEFA94A697E8Q46405748-BE719D1C-01A6-4A8E-B4DF-DF47D05F86BAQ46426248-554E9E6D-248E-4E3A-987B-66D5148BB569Q51017993-A1FD1A6F-79C7-4945-9769-BCE85D4532C5Q51296440-DDD2A66C-00FA-4907-BFE8-7648D0B14C93Q53217372-2B6E295B-9C53-4ACD-8046-B064D0A1C55DQ61796153-39311BB5-0A6A-4CA3-A392-557191392C55Q83032203-FB639AD0-74F5-4751-9BA7-E9027BF206BCQ90203813-8483C9C3-279F-4284-A432-9B467DAB3495Q90225709-73FB0C2B-25FC-4A88-B60F-6A0B824A776FQ90850408-BC0D3BD3-F132-4172-BF14-099B594CC26D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marten Beeg
@ast
Marten Beeg
@en
Marten Beeg
@es
Marten Beeg
@nl
type
label
Marten Beeg
@ast
Marten Beeg
@en
Marten Beeg
@es
Marten Beeg
@nl
prefLabel
Marten Beeg
@ast
Marten Beeg
@en
Marten Beeg
@es
Marten Beeg
@nl
P106
P1153
12774321200
P31
P496
0000-0001-7201-6704